Immediate postpartum, long-acting reversible contraceptive use among the Emergency Medicaid population: continuation rates and satisfaction - 02/04/20
Doi : 10.1016/j.ajog.2019.11.1289
Le texte complet de cet article est disponible en PDF.
Le texte complet de cet article est disponible en PDF.
Plan
| Dr Rodriguez was a Women’s Reproductive Health Research fellow when the work was conducted (grant 1K12HD085809). Dr Baldwin is a Women’s Reproductive Health Research Scholar (K12HD085809). |
|
| REDcap through OHSU was used for this study and as such this research was supported by National Center for Advancing Translational Sciences of the National Institutes of Health under award number UL1TR0002369. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health |
|
| Drs Rodriguez and Baldwin have served as contraceptive trainers for Merck. Dr Rodriguez has served on an annual advisory board for Bayer and Cooper Surgical (relationship has ended). The other authors report no conflict of interest. |
© 2019
Elsevier Inc. Tous droits réservés.
Vol 222 - N° 4S
P. S913-S914 - avril 2020 Retour au numéro
Article précédent
- An initiative to implement immediate postpartum long-acting reversible contraception in rural New Mexico
- Hannah C. Palm, James H. Degnan, Sharla D. Biefeld, Abigail L. Reese, Eve Espey, Lisa G. Hofler
- A couple-focused, integrated unplanned pregnancy and HIV prevention program in urban and rural Zambia
- Kalonde Malama, William Kilembe, Mubiana Inambao, Alexandra Hoagland, Tyronza Sharkey, Rachel Parker, Kristin M. Wall, Amanda Tichacek, Supriya Sarkar, Bellington Vwalika, Lisa Haddad, Elwyn Chomba, Susan Allen
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?